Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 11,990 | 8,070 | 6,450 | 44,670 | 2,170 |
| TOTAL | $11,990 | $8,070 | $6,450 | $44,670 | $2,170 |
| Non-Current Assets | |||||
| PPE Net | 10,400 | 7,100 | 6,530 | 6,370 | 2,880 |
| Investments And Advances | 2,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 115,680 | 3,560 | 3,780 | 3,960 | 4,150 |
| TOTAL | $128,080 | $10,660 | $10,310 | $10,330 | $7,030 |
| Total Assets | $140,070 | $18,730 | $16,760 | $55,000 | $9,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,060 | 2,280 | 2,120 | 4,070 | 2,320 |
| Accrued Expenses | 12,070 | 7,080 | 5,360 | 3,970 | 4,710 |
| Other current liabilities | 2,890 | 510 | 720 | 1,110 | 1,060 |
| TOTAL | $18,470 | $10,560 | $9,010 | $9,520 | $8,270 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 3 | 2 |
| TOTAL | $9,260 | $660 | $340 | $703 | $632 |
| Total Liabilities | $27,730 | $11,220 | $9,350 | $10,223 | $8,902 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 20 | 20 | 20 | 20 |
| Other shareholders' equity | -570 | -470 | -400 | -280 | -290 |
| TOTAL | $227,210 | $161,110 | $156,670 | $151,530 | $108,130 |
| Total Liabilities And Equity | $254,940 | $172,330 | $166,020 | $161,753 | $117,032 |